Assistant Professor, Radiation Oncology, University of Michigan Medical School
Radiation Oncology
Dr. Mary U. Feng, MD
|
|
Give Review
Mary U. Feng practices Radiation Oncology. She went to Washington University School of Medicine in St. Louis. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Mary U. Feng has written publications. She has 30 publications published with PubMed. The lastest paper is: 'Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovori...' Mary Feng accepts Medicare.
Publications
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
- Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovori...
- Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy.
- Quantitative characterizations of ultrashort echo (UTE) images for supporting air-bone separation in the head.
- Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implicati...
- Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of michigan.
- A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer.
- Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients.
- Estimating functional liver reserve following hepatic irradiation: Adaptive normal tissue response models.
- Arterial Perfusion Imaging-Defined Subvolume of Intrahepatic Cancer.
- Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy.
- Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.
- Parotid Glands Dose-Effect Relationships Based on Their Actually Delivered Doses: Implications for Adaptive Replanning in Radiation Therapy of Head-and-Neck Cancer.
- Stereotactic body radiation therapy for primary and metastatic liver tumors.
- Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises.
- Predictive Models for Regional Hepatic Function Based on 99mTc-IDA SPECT and Local Radiation Dose for Physiologic Adaptive Radiation Therapy.
- Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues.
- Protons for Prostate Cancer: the Dream Versus the Reality.
- Is There a Dose-Response Relationship for Heart Disease With Low-Dose Radiation Therapy?
- WE-A-217A-04: Hepatic Function Estimated from HIDA SPECT for Assessment of Liver Response to Radiation Therapy.
- Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning.
- Normal Tissue Anatomy for Oropharyngeal Cancer: Contouring Variability and Its Impact on Optimization.
- Dosimetric Analysis of Radiation-induced Gastric Bleeding.
- Prediction of Liver Function by Using Magnetic Resonance-based Portal Venous Perfusion Imaging.
- A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy.
- Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive do...
- The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework.
- Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT.
- Renal remodeling in the first 24 months after abdominal radiotherapy.
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
Washington University School of Medicine in St. Louis
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1720106693 | |
| NPPES Provider LastName | FENG | |
| NPPES Provider FirstName | MARY | |
| NPPES Provider ZIPCode | 481095010 | |
| NPPES Provider State | MI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 81.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720106693 |
| Last Name Of The Provider | FENG |
| First Name Of The Provider | MARY |
| View All |
Similar Doctors
|
|
Dr. James A. Hayman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Daniel A. Hamstra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina I. Tsien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lori J. Pierce, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kyle C. Cuneo, MD |
|
|
Dr. Adam L. Liss, MD |
|
|
Dr. Brooke L. Trotter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron N. Sabolch, MD
This Doctor is OpenDoctor Recommended.
|